Pharmacology, Toxicology and Pharmaceutical Science
Cannabidiol
100%
Rhesus Monkey
99%
Oxycodone
99%
Cannabis
76%
Kappa Opiate Receptor Agonist
73%
Nalfurafine
63%
Pharmacodynamics
60%
Tetrahydrocannabinol
54%
Normal Human
47%
Guanine Nucleotide Binding Protein
44%
Cannabis Sativa
42%
Mu Opiate Receptor Agonist
41%
Placebo
38%
Triazole
37%
Cannabinoid
37%
Pharmacokinetics
33%
Ethanol
33%
Pharmacokinetics
28%
Antinociception
24%
Opiate
24%
Duragesic
21%
Cytochrome P450
19%
Behavioral Effect
17%
Cannabinoid
16%
Clinical Study
15%
Dronabinol
15%
Drug Interaction
14%
Buprenorphine
14%
Randomized Clinical Trial
14%
Alprazolam
14%
Naltrexone
14%
Oliceridine
14%
Limonene
14%
Cross Sectional Study
14%
Methadone
14%
Cosmetics
14%
Respiration Depression
14%
Withdrawal Syndrome
14%
Chewing Tobacco
14%
Randomized Controlled Trial
14%
Tetrahydrocannabinolic Acid
14%
Homo sapiens
14%
Salvinorin A
11%
Kappa Opiate Receptor
9%
Side Effect
8%
Haplorhini
7%
Illicit Drug
7%
Disease
6%
Tetrahydrocannabivarin
5%
Keyphrases
Cannabidiol
60%
Rhesus Monkey
57%
Oxycodone
45%
Nalfurafine
42%
Self-administration
35%
Δ9-tetrahydrocannabinol (Δ9-THC)
29%
Kappa Opioid Receptor Agonist
29%
Oxycodone Self-administration
28%
Sleeve Gastrectomy
28%
Cannabinoids
24%
μ-Opioid Receptor Agonist
22%
Pharmacokinetics
21%
Μ-Opioid Receptor Agonist
20%
Fentanyl
18%
Cannabis
16%
Orally Administered
16%
Pharmacodynamics
16%
Rodent Models
16%
Male Rats
15%
Healthy Adults
15%
Antinociceptive
15%
Caffeine
14%
Oral Cannabis
14%
Metabolic Disease
14%
Progressive Ratio Schedule
14%
Kappa Opioid
14%
Rodents
14%
Urinary Excretion
14%
Pharmacodynamic Interactions
14%
Alprazolam
14%
Fetoplacental
14%
Naltrexone
14%
Acute Administration
14%
STISIM
14%
Buprenorphine
14%
Alcohol Seeking
14%
Excretion Profile
14%
Human Laboratory Studies
14%
Rewarding Effect
14%
Baboon
14%
Surgical Menopause
14%
TRV130
14%
Observable Behaviors
14%
Vaporized Cannabis
14%
Variable Schedule
14%
Block Acquisition
14%
Pharmacokinetic Effects
14%
Analytical Toxicology
14%
Cannabis Users
14%
Immune Health
14%
Medicine and Dentistry
Cannabis
39%
Sleeve Gastrectomy
28%
Cannabidiol
27%
Cannabinoid
20%
Placebo
17%
In Vitro
15%
Water-Electrolyte Imbalance
14%
Tetrahydrocannabinol
14%
Cytochrome P450
14%
Drug Interaction
14%
Cross Sectional Study
14%
Clinical Study
14%
Cigarette Smoking
14%
Harm Reduction
14%
Public Health
14%
Randomized Controlled Trial
14%
Smokeless Tobacco
14%
Withdrawal Syndrome
14%
Tobacco Leaf
14%
Tetrahydrocannabivarin
5%